Serialization of own brand products in the pharmaceutical environment

For more than two years, the Del­e­gat­ed Reg­u­la­tion (EU) 2016/161 for the pro­tec­tion of pre­scrip­tion med­i­cines has now reg­u­lat­ed the coun­ter­feit pro­tec­tion of these very med­i­cines that require a pre­scrip­tion. By sign­ing the con­tract on May 6, 2021, the phar­ma­ceu­ti­cal com­pa­ny Pohl-Boskamp decid­ed to imple­ment the com­plex require­ments with the help of the “Arva­to CSDB” soft­ware solution.

No pre­scrip­tion med­ica­tion may be in cir­cu­la­tion with­in the EU with­out a unique QR code as well as a device to pre­vent tam­per­ing. Cor­re­spond­ing mea­sures enable the ver­i­fi­ca­tion of med­i­cines for their iden­ti­ty, authen­tic­i­ty and integri­ty. The aim of the sys­tem is to pre­vent coun­ter­feit med­i­cines from enter­ing the legal sup­ply chain.

Pohl-Boskamp mar­kets its brand­ed prod­ucts world­wide. As a medi­um-sized com­pa­ny, effi­cient and cost-effec­tive main­te­nance of the sys­tem as well as fast and dynam­ic imple­men­ta­tion of new require­ments are essen­tial for the com­pa­ny’s success.

“Arva­to CSDB” replaces the het­ero­ge­neous seri­al­iza­tion solu­tion pre­vi­ous­ly in use at the group, which con­sist­ed of dif­fer­ent sys­tems for dif­fer­ent mar­kets. The aim is to ensure the glob­al mar­ket­ing of the prod­uct port­fo­lio in the long term. In addi­tion to the effi­cien­cy gains, glob­al mar­ket require­ments, such as in Rus­sia, should be able to be imple­ment­ed faster and more cost-effec­tive­ly than before with­in the scope of seri­al­iza­tion. The “Arva­to CSDB” as a Ser­vice solu­tion will be used to replace part of the exist­ing system.

In addi­tion to imple­ment­ing the “Arva­to CSDB”, Arva­to Sys­tems will also pro­vide Pohl-Boskamp with con­sult­ing ser­vices and sup­port in imple­ment­ing or main­tain­ing the dynam­ic require­ments on a glob­al level.

“Dur­ing the selec­tion process, Arva­to Sys­tems con­vinced us of the added val­ue of the ‘Arva­to CSDB’ solu­tion and of its tech­ni­cal exper­tise around glob­al seri­al­iza­tion require­ments through its com­pe­tent sup­port. We are very much look­ing for­ward to a suc­cess­ful and long-term cooperation.”

- Ulrich Zinn, Head of Sup­ply Chain

 

“I am very hap­py about the new part­ner­ship with the his­toric fam­i­ly-owned phar­ma­ceu­ti­cal com­pa­ny in Ger­many. We are very pleased to be able to con­tribute a part to the strate­gic adjust­ments in the con­text of seri­al­iza­tion so that the com­pa­ny can con­tin­ue to suc­cess­ful­ly posi­tion its prod­uct port­fo­lio world­wide in the future,” said Pas­cal Lep­pich, Senior Sales Man­ag­er at Arva­to Sys­tems, affirm­ing the impor­tance of the partnership.